Skip to content
sellWeak10b5-1 plan

Michael Feld sold $10k of BDX

EVP & President, Life Sciences at BECTON DICKINSON & CO. 58 shares at an average of $181.03, traded Sep 26, 2025, filed Sep 29, 2025.

Warning score
0
Value
$10k
58 shares
Holdings after
8,302
-1% from before
From 52-week low
+13%
low $125.23, close $141.59
From 52-week high
-25%
high $188.01, as of Sep 26, 2025

Score components

  • Role
    Officer
    +15
  • Trade size
    $10k at market
    0
  • Share of holdings sold
    Sold 0.7% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

BDXOct 9, 2026 · close 183.75
Since filing Sep 29, 2025: +30.2%SPY +18.6% · excess +11.6%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001628280-25-043134, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Sep 26, 2025SOpen-market sale
Common Stock10b5-1
-58$181.03$10k8,302Sep 29, 2025

Related signals

Other insiders at BECTON DICKINSON & CO and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
0Weak
BDXsell10b5-1
BECTON DICKINSON & CO
Michael Feld
EVP, Chief Revenue Officer
$14k
76 shares
-0%
3Weak
BDXsell 210b5-1
BECTON DICKINSON & CO
Michael Feld
EVP, Chief Revenue Officer
$11k
75 shares
-0%
14Weak
BDXsell 210b5-1
BECTON DICKINSON & CO
Michael David Garrison
EVP & Pres Med.Essntl&BioPharm
$160k
1,100 shares
-8%
14Weak
BDXsell 210b5-1
BECTON DICKINSON & CO
Michael David Garrison
EVP & Pres Med.Essntl&BioPharm
$167k
1,100 shares
-7%
21Weak
BDXsell 310b5-1
BECTON DICKINSON & CO
Thomas E Polen Jr
Chairman, CEO and President
$405k
2,764 shares
-2%
3Weak
BDXsell 210b5-1
BECTON DICKINSON & CO
Michael Feld
EVP, Chief Revenue Officer
$11k
75 shares
-0%
0Weak
BDXsell10b5-1
BECTON DICKINSON & CO
Michael Feld
EVP, Chief Revenue Officer
$11k
74 shares
-0%
0Weak
BDXsell10b5-1
BECTON DICKINSON & CO
Michael Feld
EVP, Chief Revenue Officer
$12k
75 shares
-0%
3Weak
BDXsell 210b5-1
BECTON DICKINSON & CO
Michael Feld
EVP, Chief Revenue Officer
$14k
75 shares
-0%
34Weak
BDXsell 2
BECTON DICKINSON & CO
Bertram L Scott
director
$174k
953 shares
-3%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.